Pegmolesatide
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pegmolesatide, covering 2025-04-27 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI) [NA]